• Regulatory NewsRegulatory News

    Trump: Drug Importation Coming Soon

    In remarks related to an executive order on Medicare, President Donald Trump on Thursday gave a speech filled with falsehoods about the Right-to-Try law, claims that drugmakers would lower their prices once importation begins and a suggestion that the pharmaceutical industry is aiding his impeachment. Trump also read from the teleprompter to explain a proposal that’s coming soon to lower drug prices by importing drugs from Canada and other countries. First revealed in ...
  • Regulatory NewsRegulatory News

    Democrats, Republicans Unveil Drug Pricing Bills

    As a new Congressional term kicks off, Democrats and Republicans in Congress, as well as the Trump administration, are pushing policies to lower prescription drug prices.   On Wednesday, Sens. Chuck Grassley (R-IA) and Amy Klobuchar (D-MN) introduced a bill, dubbed the Safe and Affordable Drugs from Canada Act of 2019, that would allow for Americans to import drugs from Canada. The bill mirrors the bill by the same name championed by the late Sen. John McCain (R-AZ...
  • Regulatory NewsRegulatory News

    EMA Looks to Clarify Import Requirements for Finished Products

    The European Medicines Agency (EMA) is looking to expand its guidance for companies importing finished medicinal products to the EU, in response to increasing globalization and supply chain complexity. Importation Requirements In the EU, companies importing finished medicinal products are required to obtain a manufacturing and importation authorisation (MIA) issued by their local national competent authority. To comply with the regulations, importers must follow good ...